Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type 1 selected

Type

Guidance programme

Showing 1151 to 1175 of 2013

TitleReference numberPublishedLast updated
Tests in secondary care to identify people at high risk of ovarian cancerHTG453
Regorafenib for previously treated unresectable or metastatic gastrointestinal stromal tumoursTA488
Total distal radioulnar joint replacement for symptomatic joint instability or arthritisHTG451
Extracranial to intracranial bypass for intracranial atherosclerosisHTG452
Sarilumab for moderate to severe rheumatoid arthritisTA485
Aflibercept for treating choroidal neovascularisationTA486
Sinusitis (acute): antimicrobial prescribingNG79
Cataracts in adults: managementNG77
Cystic fibrosis: diagnosis and managementNG78
Hepatitis B (chronic): diagnosis and managementCG165
Immunosuppressive therapy for kidney transplant in adultsTA481
Immunosuppressive therapy for kidney transplant in children and young peopleTA482
Tofacitinib for moderate to severe rheumatoid arthritisTA480
Child abuse and neglectNG76
Brentuximab vedotin for treating relapsed or refractory systemic anaplastic large cell lymphomaTA478
Reslizumab for treating severe eosinophilic asthmaTA479
Autologous chondrocyte implantation for treating symptomatic articular cartilage defects of the kneeTA477
Faltering growth: recognition and management of faltering growth in childrenNG75
Intramuscular diaphragm stimulation for ventilator-dependent chronic respiratory failure caused by motor neurone diseaseHTG450
Cetuximab and panitumumab for previously untreated metastatic colorectal cancerTA439
Intermediate care including reablementNG74
Type 2 diabetes: prevention in people at high riskPH38
High-intensity focused ultrasound for symptomatic breast fibroadenomaHTG449
Ab externo canaloplasty for primary open-angle glaucomaHTG448
Pembrolizumab for advanced melanoma not previously treated with ipilimumabTA366

Results per page

  1. 10
  2. 25
  3. 50
  4. All